Nilotinib Effects in Parkinson’s disease and Dementia with Lewy bodies

por Pagan, Fernando, Hebron, Michaeline, Valadez, Ellen H., Torres-Yaghi, Yasar, Huang, Xu, Mills, Reversa R., Wilmarth, Barbara M., Howard, Hellen, Dunn, Connell, Carlson, Alexis, Lawler, Abigail, Rogers, Sean L., Falconer, Ramsey A., Ahn, Jaeil, Li, Zhaoxia, Moussa, Charbel
Publicado 2016

Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease

por Pagan, Fernando L., Hebron, Michaeline L., Wilmarth, Barbara, Torres‐Yaghi, Yasar, Lawler, Abigail, Mundel, Elizabeth E., Yusuf, Nadia, Starr, Nathan J., Arellano, Joy, Howard, Helen H., Peyton, Margo, Matar, Sara, Liu, Xiaoguang, Fowler, Alan J., Schwartz, Sorell L., Ahn, Jaeil, Moussa, Charbel
Publicado 2019

Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial

por Pagan, Fernando. L., Hebron, Michaeline L., Wilmarth, Barbara, Torres-Yaghi, Yasar, Lawler, Abigail, Mundel, Elizabeth E., Yusuf, Nadia, Starr, Nathan J., Anjum, Muhammad, Arellano, Joy, Howard, Helen H., Shi, Wangke, Mulki, Sanjana, Kurd-Misto, Tarick, Matar, Sara, Liu, Xiaoguang, Ahn, Jaeil, Moussa, Charbel
Publicado 2020

Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease

por Turner, Raymond S., Hebron, Michaeline L., Lawler, Abigail, Mundel, Elizabeth E., Yusuf, Nadia, Starr, J. Nathan, Anjum, Muhammad, Pagan, Fernando, Torres‐Yaghi, Yasar, Shi, Wangke, Mulki, Sanjana, Ferrante, Dalila, Matar, Sara, Liu, Xiaoguang, Esposito, Giuseppe, Berkowitz, Frank, Jiang, Xiong, Ahn, Jaeil, Moussa, Charbel
Publicado 2020